CAMTA1 — gene · CancerIndex

Curated evidence

Clinical evidence (4)

CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.

civicCuratedShowing 1–4 of 4 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Cancer	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
CAMTA1 Fusion4
(diagnostic)	Malignant Epithelioid HemangioendotheliomaUNRESOLVED	Diagnostic	B	Supports Positive	4	accepted	EID1805 In this 2011 study, the authors investigated the genes involved in the t(1;3)(p36.3;q25) translocation associated with epithelioid hemangioendothelioma (EHE) and its prevalence in a large spectrum of … (full text at CIViC) PMID 21584898 · Errani et al., 2011 · Open in CIViC	civic
〃	Malignant Epithelioid HemangioendotheliomaUNRESOLVED	Diagnostic	B	Supports Positive	4	accepted	EID12017 In this 2011 study, the authors identified the genes involved in a reciprocal t(1;3)(p36;q25) translocation that had been detected in epithelioid haemangioendothelioma (EHE) by karyotype. RNA isolated… (full text at CIViC)

Cohorts

Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.

gdcObserved29 cohort rows · frequency = affected / profiled, as published by each cohort; cohorts are not pooled. Hover a row badge for its release.

Cohort	Mapped cancer	Alteration	Affected (n)	Profiled (n)	Frequency (%)	Rank in cohort	Source
Cholangiocarcinoma TCGA-CHOL	Cholangiocarcinoma	Ssm

Literature

25 per page, newest first.

pubmedPublishedShowing 1–3 of 3 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.